Redwire Stock Surges 24% in August on Strong Earnings and New Contracts
In August, Redwire (NYSE: RDW) saw its stock rise by 24%, driven largely by strong second-quarter earnings that exceeded analyst expectations. The company reported a nearly 90% year-over-year revenue increase to $117 million, setting new records for both sales and project backlog, which reached over $542 million—a 32% jump from the end of 2025. Despite these gains, Redwire remained unprofitable under GAAP accounting with a net loss of nearly $41 million. However, this marked an improvement compared to its previous year's deficit and was significantly better than expected on both revenue and adjusted earnings per share bases. The company attributed much of the growth to new contracts for products like Penguin drones and collaborations in pharmaceutical research. Redwire maintained its full-year revenue guidance between $450 million and $500 million, indicating at least 34% year-over-year growth. Recent developments include a collaboration with SpaceX's Starfall mission through Redwire’s SpaceMD unit to provide microgravity drug development opportunities.
Tickers: $RDW